Drug pricing

Europe races to placate pharma as Trump turns up the pressure

This content was published on Dec 29, 2025 Tariff deals with the US have bought time but investment momentum is elsewhere.

Ethylene: Clariant rejects MOL and Braskem accusations

Drug pricing

Clariant rejects complaints over EU ethylene antitrust case

This content was published on Dec 22, 2025 Chemicals manufacturer Clariant has rejected two complaints for breaches of competition law on the ethylene purchasing market.

Healthcare costs and old-age provision concern the Swiss

Drug pricing

Healthcare costs and financial security in old-age are biggest Swiss worries

This content was published on Dec 9, 2025 Swiss worry most about rising health costs and old-age financial security,

Drug pricing

Medicines ‘never more expensive in Switzerland’

This content was published on Dec 2, 2025 Costs for Swiss medicines rose year-on-year by 3.6% to a record CHF9.4 million.

Drug pricing

Timeline: How US President Trump upended the pharma industry in 2025

This content was published on Nov 18, 2025 US President Trump's tariffs and price reforms have disrupted the pharmaceutical industry in 2025.

Lower prices for 300 drugs, savings of around 65 million

Drug pricing

Switzerland lowers prices of 300 drugs

This content was published on Nov 6, 2025 Swiss public health office says it has generating savings of at least CHF65 million.

Drug pricing

Swiss women forced to pay for hormone therapy after price dispute

This content was published on Nov 6, 2025 A well-known brand of hormone therapy will no longer be covered by Swiss health insurance. What's behind the decision?

Companies are developing pills to make it easier to administer weight-loss drugs rather than injections.

Healthcare innovation

The race to launch a pill for weight loss

This content was published on Oct 30, 2025 Despite success with injectable drugs pharma companies are investing heavily in tablets, long considered the holy grail of obesity medicine.

Two white drug tablets on a red background.

Drug pricing

Swiss drugmakers face mixed fortunes amid Trump’s tariff upheaval

This content was published on Oct 8, 2025 Pharma giants may escape the worst of the import tariffs threatened by the US. But Switzerland’s smaller developers face a more uncertain future.

Health insurance premiums rise more than forecast (study)

Health systems

Study: Swiss health insurance premiums to rise higher than forecast

This content was published on Oct 2, 2025 Swiss health insurance premiums will rise up to 7.1% in 2024, higher than official forecasts.

Drug pricing

Popular Stories

Most Discussed

Sign in and personalize Swissinfo

Drug pricing

More

Europe races to placate pharma as Trump turns up the pressure

More

Clariant rejects complaints over EU ethylene antitrust case

More

Healthcare costs and financial security in old-age are biggest Swiss worries

More

Medicines ‘never more expensive in Switzerland’

More

Timeline: How US President Trump upended the pharma industry in 2025

More

Switzerland lowers prices of 300 drugs

More

Swiss women forced to pay for hormone therapy after price dispute

More

The race to launch a pill for weight loss

More

Swiss drugmakers face mixed fortunes amid Trump’s tariff upheaval

More

Study: Swiss health insurance premiums to rise higher than forecast

Popular Stories

Most Discussed